Regional Health Properties, Inc. (RHEP)
OTCMKTS
· Delayed Price · Currency is USD
1.350
-0.150 (-10.00%)
Feb 21, 2025, 3:00 PM EST
RHEP Revenue
Regional Health Properties had revenue of $3.73M in the quarter ending September 30, 2024, a decrease of -4.68%. This brings the company's revenue in the last twelve months to $15.75M, down -26.23% year-over-year. In the year 2023, Regional Health Properties had annual revenue of $16.01M, down -48.36%.
Revenue (ttm)
15.75M
Revenue Growth
-26.23%
P/S Ratio
0.16
Revenue / Employee
138.18K
Employees
114
Market Cap
2.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.01M | -15.00M | -48.36% |
Dec 31, 2022 | 31.01M | 4.50M | 16.98% |
Dec 31, 2021 | 26.51M | 9.85M | 59.17% |
Dec 31, 2020 | 16.65M | -3.76M | -18.42% |
Dec 31, 2019 | 20.42M | 2.50M | 13.96% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |